Sundaram Multi Pap Intrinsic Value
Sundaram Multi Pap intrinsic value. Sundaram Multi Pap (SUNDARAM) median intrinsic value is ₹2.73 from 4 valuation models (range ₹2–₹3), vs current price ₹1.09 — +150.5% upside (Trading Below Calculated Value), margin of safety 60.1%. For current market price and key ratios, visit SUNDARAM stock price BSE.
SUNDARAM Valuation Methods Summary — DCF, Graham Number & P/E
Sundaram Multi Pap intrinsic value across 4 models vs current price ₹1.09 — upside/downside and value range per method. Read Sundaram Multi Pap dividend payments for the complete payout history and dividend yield track record.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹2.73 | ₹2.46 - ₹3.00 | +150.5% | Book Value/Share: ₹35.56, P/B: 2.5x |
| Revenue Multiple Method | revenue | ₹2.18 | ₹1.96 - ₹2.40 | +100.0% | Revenue/Share: ₹38.52, P/S: 1.5x |
| EBITDA Multiple Method | earnings | ₹2.18 | ₹1.96 - ₹2.40 | +100.0% | EBITDA: ₹4.00Cr, EV/EBITDA: 12x |
| Simple DCF (5Y) | dcf | ₹2.73 | ₹2.18 - ₹3.28 | +150.5% | CF Growth: 5.0%, Discount: 15% |
SUNDARAM Intrinsic Value vs Market Price — All Valuation Models
Sundaram Multi Pap fair value range ₹2–₹3 vs current market price ₹1.09 across 4 valuation models. Compare with SUNDARAM fair value estimate to assess whether the stock is under or overvalued.
SUNDARAM Intrinsic Value Analysis — Undervalued or Overvalued?
Sundaram Multi Pap median intrinsic value ₹2.73, current price ₹1.09 — Trading Below Calculated Value by 150.5%, margin of safety 60.1%.
What is the intrinsic value of SUNDARAM?
Based on our comprehensive analysis using 4 different valuation methods, the estimated intrinsic value of Sundaram Multi Pap (SUNDARAM) is ₹2.73 (median value). With the current market price of ₹1.09, this represents a +150.5% variance from our estimated fair value.
The valuation range spans from ₹2.18 to ₹2.73, indicating ₹2.18 - ₹2.73.
Is SUNDARAM undervalued or overvalued?
Based on our multi-method analysis, Sundaram Multi Pap (SUNDARAM) appears to be trading below calculated value by approximately 150.5%.
SUNDARAM Financial Health — Key Ratios vs Industry Benchmarks
Sundaram Multi Pap financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 93.00 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | -12.5% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 3.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.68x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
SUNDARAM Cash Flow Quality — Operating & Free Cash Flow
Sundaram Multi Pap operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2019 | ₹8 Cr | ₹6 Cr | Positive Free Cash Flow | 8/10 |
| March 2018 | ₹5 Cr | ₹5 Cr | Positive Free Cash Flow | 8/10 |
| March 2017 | ₹2 Cr | ₹2 Cr | Positive Free Cash Flow | 8/10 |
| March 2016 | ₹23 Cr | ₹23 Cr | Positive Free Cash Flow | 8/10 |
| March 2015 | ₹26 Cr | ₹26 Cr | Positive Free Cash Flow | 8/10 |